# reload+after+2024-01-23 03:43:17.379672
address1§24 School Street
address2§2nd Floor
city§Boston
state§MA
zip§02108
country§United States
phone§401 426 4664
website§https://www.allarity.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Thomas H. Jensen', 'age': 45, 'title': 'Founder, CEO, Senior VP of Investor Relations & Director', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Joan Y. Brown', 'age': 70, 'title': 'Interim CFO', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 180000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Marie  Foegh DrSc, M.D.', 'age': 80, 'title': 'Chief Medical Officer', 'yearBorn': 1943, 'fiscalYear': 2022, 'totalPay': 340309, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Peter Buhl Jensen Adj Professor, M.D., M.D., Ph.D., Ph.D.', 'age': 68, 'title': 'Co-Founder', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 546080, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steen Meier Knudsen Ph.D.', 'age': 62, 'title': 'Founder & Chief Scientific Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 185112, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.115
currency§USD
dateShortInterest§1702598400
forwardEps§-0.56
exchange§NCM
quoteType§EQUITY
shortName§Allarity Therapeutics, Inc.
longName§Allarity Therapeutics, Inc.
firstTradeDateEpochUtc§1640097000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§069341ee-08be-3463-988c-4bfe8cb84acd
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§0.196
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
